Skip to content
Screener

AnaptysBio, Inc. ANAB Royalty Management Company — Net Income Loss

Other segment segments

Biopharma Company
-$50.48M

Similar metrics at other companies

Bank of the James Financial Group logo
BOTJHolding Company — Net Income Loss
$760K-9.6%
Orange County Bancorp logo
OBTWealth Management — Net Income Loss
$842K-1.2%
First National Corp. logo
FXNCWealth Management — Net Income Loss
$313K+4.7%
First United logo
FUNCWealth Management — Net Income Loss
$1.15M+7.6%
KULR Technology Group logo
KULREnergy Management Platform — Net Income Loss
-$6.78M+24.4%
Duos Technologies Group, Inc. logo
DUOTAsset Management Services — Net Income Loss
$1.01M-19.4%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.62B+145%
Enterprise value$1.37B+117%
P/S+1.6×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219515
Line itemBiopharmaRoyalty ManagementTotal
(Loss) income from operations(52,811)18,174(34,637)
Interest income2,3283252,653
Non-cash interest expense(20,859)(20,859)
Other expense, net(1)(1)
Total other income (expense), net2,327(20,534)(18,207)
Loss before income taxes(50,484)(2,360)(52,844)
Provision for income taxes(40)(40)
Segment net loss(50,484)(2,400)(52,884)

Item 1. Consolidated Financial Statements

FAQ

What is AnaptysBio, Inc.'s royalty management company — net income loss?
AnaptysBio, Inc. (ANAB) reported royalty management company — net income loss of -$2.4M in Q1 2026.
How has AnaptysBio, Inc.'s royalty management company — net income loss changed year-over-year?
AnaptysBio, Inc.'s royalty management company — net income loss decreased by 130.5% year-over-year, from $7.87M to -$2.4M.
What does royalty management company — net income loss mean?
This metric measures the bottom-line profitability of the royalty management segment after accounting for all associated revenues, operating expenses, and non-operating items. It serves as a primary indicator of the segment's financial viability and its contribution to the overall corporate earnings. A positive value indicates that the royalty-generating assets are successfully covering their operational and financing costs.

Ask your AI about AnaptysBio, Inc.'s royalty management company — net income loss.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude